About Jeffrey Carper
Form D filings for CorriXR Therapeutics from 2022 to 2024 list Jeffrey Carper as director.
Jeffrey Carper first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Jeffrey Carper in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Jeffrey Carper works with at each company, as listed on that company's latest Form D.
CorriXR Therapeutics, Inc. · Form D/A, Jan 29, 2024
JB
Jon Brilliant
Executive officer
DM
Deborah Moorad
Chief Executive Officer and director
JN
Janice Nevin
Director
SV
Stella Vnook
Director
EK
Eric Kmiec
Executive officer and director